ATE96323T1 - Arzneimittel und methode zur steigerung der mikrozirkulaetorischen durchfluss-rate sowie des volumens in den kapillargefaessen der haut. - Google Patents

Arzneimittel und methode zur steigerung der mikrozirkulaetorischen durchfluss-rate sowie des volumens in den kapillargefaessen der haut.

Info

Publication number
ATE96323T1
ATE96323T1 AT89111110T AT89111110T ATE96323T1 AT E96323 T1 ATE96323 T1 AT E96323T1 AT 89111110 T AT89111110 T AT 89111110T AT 89111110 T AT89111110 T AT 89111110T AT E96323 T1 ATE96323 T1 AT E96323T1
Authority
AT
Austria
Prior art keywords
drug
skin
volume
increase
flow rate
Prior art date
Application number
AT89111110T
Other languages
English (en)
Inventor
Curri Sergio Bertini
Original Assignee
Curri Sergio Bertini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curri Sergio Bertini filed Critical Curri Sergio Bertini
Application granted granted Critical
Publication of ATE96323T1 publication Critical patent/ATE96323T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89111110T 1988-11-16 1989-06-19 Arzneimittel und methode zur steigerung der mikrozirkulaetorischen durchfluss-rate sowie des volumens in den kapillargefaessen der haut. ATE96323T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8822640A IT1231260B (it) 1988-11-16 1988-11-16 Farmaco e metodo per aumentare volume e velocita' del flusso microcircolatorio capillare a livello cutaneo
EP89111110A EP0369105B1 (de) 1988-11-16 1989-06-19 Arzneimittel und Methode zur Steigerung der mikrozirkulätorischen Durchfluss-Rate sowie des Volumens in den Kapillargefässen der Haut

Publications (1)

Publication Number Publication Date
ATE96323T1 true ATE96323T1 (de) 1993-11-15

Family

ID=11198740

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89111110T ATE96323T1 (de) 1988-11-16 1989-06-19 Arzneimittel und methode zur steigerung der mikrozirkulaetorischen durchfluss-rate sowie des volumens in den kapillargefaessen der haut.

Country Status (6)

Country Link
US (1) US5280020A (de)
EP (1) EP0369105B1 (de)
AT (1) ATE96323T1 (de)
CA (1) CA1333999C (de)
DE (1) DE68910275T2 (de)
IT (1) IT1231260B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4037658C2 (de) * 1990-02-10 1993-11-04 Nattermann A & Cie Verwendung von derivaten des 2',4', 6'-trimethoxy-4-(1-pyrrolidinyl) butyrophenon
IT1251840B (it) * 1991-09-20 1995-05-26 Schiena Ricerche Uso di formulazioni liposomiali contenenti papaverina nel trattamento della impotenza maschile
US6733776B1 (en) 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
ATE209887T1 (de) * 1993-04-02 2001-12-15 Anticancer Inc Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
US7556825B2 (en) 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
IT1269634B (it) * 1994-05-06 1997-04-08 Indena Spa Medicamento topico ad attivita' cicatrizzante
US6844326B2 (en) 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
GB2331528B (en) * 1997-11-20 2002-03-13 Unilever Plc Hair treatment composition
MX2008014450A (es) * 2006-05-18 2009-03-09 Mannkind Corp Inhibidores de cinasa intracelular.
US20100099640A1 (en) 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
CN116406379A (zh) 2020-10-22 2023-07-07 瑞泽恩制药公司 抗fgfr2抗体和其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092133B1 (de) * 1970-05-06 1974-03-22 Orsymonde
FR2134218A1 (en) * 1971-04-27 1972-12-08 Penciolelli Madeleine Phloroglucinol aminoketones - vasodilators and antispasmodics
US4742051A (en) * 1977-06-30 1988-05-03 University Of Tennessee Research Corporation Antihypertensive compounds
FR2539626B2 (fr) * 1983-01-25 1985-06-21 Lafon Labor Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
EP0204987B1 (de) * 1985-05-15 1991-11-21 Roshdy Dr. Ismail Vitamin E-haltiges Mittel zur Verbesserung der Eigenschaften des Blutes

Also Published As

Publication number Publication date
CA1333999C (en) 1995-01-17
DE68910275T2 (de) 1994-02-24
EP0369105A1 (de) 1990-05-23
IT8822640A0 (it) 1988-11-16
US5280020A (en) 1994-01-18
EP0369105B1 (de) 1993-10-27
DE68910275D1 (de) 1993-12-02
IT1231260B (it) 1991-11-28

Similar Documents

Publication Publication Date Title
Fabing et al. Intravenous bufotenine injection in the human being
Wit et al. Temperature-sensitive neurons in preoptic-anterior hypothalamic region: actions of pyrogen and acetylsalicylate
ATE96323T1 (de) Arzneimittel und methode zur steigerung der mikrozirkulaetorischen durchfluss-rate sowie des volumens in den kapillargefaessen der haut.
FI870219A (fi) Hypoglykemiska tiazolidindioner.
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
ATE81282T1 (de) Photostabile lichtfiltrierende kosmetische zusammensetzung in form einer eine wasserloesliche filtersubstanz mit breitem absorptionsband und mindestens eine fettloesliche uv-a-filtersubstanz enthaltenden emulsion.
KR890015742A (ko) 이병치료용 국소 제제
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
ATE195872T1 (de) Aufbewahren von stammzellen
DK0514367T3 (da) Lægemiddel indeholdende protein C
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
DE59003020D1 (de) Piroxicam enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
KR930019224A (ko) 유산 위험 치료제
DK633989A (da) Laegemiddelforstadier til 3,4-hydroxy-benzoyloxypropanolaminer og deres anvendelse
ATE243527T1 (de) Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen
EP0305277A3 (de) Verwendung von 2-Amino-6-trifluormethoxybenzthiazol zur Herstellung eines Arzneimittels zur Behandlung von Schlafstörungen und Depressionen
ATE233085T1 (de) Arzneimittel zur topischen anwendung
ATE144780T1 (de) Megakaryocytopoietischer faktor
ATE139703T1 (de) Aureobasidin enthaltendes arzneimittel
ES2031846T3 (es) Compuesto medico que contiene tpa y uso del mismo.
DE69623641D1 (de) Topisch anzuwendendes abschäumendes arzneimittel zur behandlung von durch pityrosporum ovale verursachten hauterkrankungen
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties